CTKB — Cytek Biosciences, Inc.

Nasdaq · Unknown · Unknown · CIK 1831915 ·
Last close
$3.97
Market Cap
$512.70M
52W High
$4.99
52W Low
$3.31
ADV30
872,083
Next earnings
2026-08-06
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 44,135,000 21,254,000 -18,463,000 -18,866,000 449,113,000 65,665,000 121,469,000
Dec 2025 62,141,000 32,885,000 -5,594,000 -44,076,000 461,542,000 90,853,000 119,803,000
Sep 2025 52,293,000 27,551,000 -9,192,000 -5,478,000 494,919,000 93,281,000 116,348,000
Jun 2025 45,602,000 23,867,000 -10,624,000 -5,583,000 493,320,000 75,470,000 115,763,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,686,000
Investing CF
$10,118,000
Financing CF
$-13,433,000
CapEx
$-4,190,000
Dividends Paid
Buybacks
$-15,074,000
EPS Diluted TTM
$-0.51
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-101,738,000
Inventory
$48,428,000
Receivables
$72,127,000
ST Investments
$170,676,000
EBIT TTM
$-29,367,000
Pretax Income TTM
$-29,841,000
Interest Exp TTM
$474,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$204,171,008
EBITDA
$-36,303,000
Free Cash Flow
$6,412,875
Enterprise Value
$283,118,784
Total Cash
$262,224,992
Total Debt
$27,482,000
Shares Out
129,142,587
Trailing EPS
$-0.58
Book Value
$2.54
ROE
-20.9%
ROA
-5.9%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 201,493,000 -40,384,000 -66,539,000 461,542,000 119,803,000 -4,686,000
Dec 2024 200,453,000 -20,523,000 -6,020,000 499,500,000 103,763,000 25,379,000
Dec 2023 193,015,000 -27,845,000 -12,148,000 494,457,000 101,393,000 5,281,000
Dec 2022 164,036,000 -1,804,000 2,576,000 519,476,000 93,930,000 -12,231,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.19

News headlines (Yahoo Finance, 1h cache)

Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
2026-05-20 20:51 · Yahoo
Cytek (CTKB) Q1 2026 Earnings Call Transcript
2026-05-08 14:32 · Yahoo
Cytek Biosciences, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates
2026-05-07 23:05 · Yahoo
Cytek Biosciences Q1 Earnings Call Highlights
2026-05-07 21:39 · Yahoo
Cytek Biosciences Reports First Quarter 2026 Financial Results
2026-05-07 20:05 · Yahoo
AbCellera Biologics Among 3 Promising Penny Stocks
2026-05-01 12:05 · Yahoo
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-23 20:05 · Yahoo
Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates
2026-04-14 05:29 · Yahoo
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist
2026-03-25 12:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.